日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of Prophylactic EGD versus Beta Blockade in Hepatocellular Carcinoma Patients on Anti-Angiogenic Cancer Treatments

评估预防性 EGD 与 β 受体阻滞剂在接受抗血管生成癌症治疗的肝细胞癌患者中的疗效

Kontoyiannis, Panayiotis D; Ayerbe, Camila; Chan, Kok Hoe; Soliman, Sara; Machicao, Victor; Rowe, Julie H

Anti-tumor activity of camptothecin analog conjugate of an RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer

喜树碱类似物缀合物与靶向LGR4/5/6的RSPO4基肽抗体在结直肠癌临床前模型中的抗肿瘤活性

Toh, Yukimatsu; Wu, Ling; Tu, Jianghua; Liang, Zhengdong; Aldana, Adela M; Wen, Jake J; Li, Li; Pan, Sheng; Rowe, Julie H; Hensel, Martha E; Hodo, Carolyn L; Finch, Rick A; Carmon, Kendra S; Liu, Qingyun J

An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer.

针对 GPR56 的抗体药物偶联物在结直肠癌的临床前模型中显示出疗效

Jacob Joan, Francisco Liezl E, Chatterjee Treena, Liang Zhengdong, Subramanian Shraddha, Liu Qingyun J, Rowe Julie H, Carmon Kendra S

How does the tumor microenvironment play a role in hepatobiliary tumors?

肿瘤微环境在肝胆肿瘤中发挥什么作用?

Kamil, Fathima; Rowe, Julie H

Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis

肝细胞癌综述:流行病学、病因学和致癌作用

Ghouri, Yezaz Ahmed; Mian, Idrees; Rowe, Julie H

Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia

血红蛋白尿与慢性肾脏病及其在镰状细胞贫血患者中的进展有关

Saraf, Santosh L; Zhang, Xu; Kanias, Tamir; Lash, James P; Molokie, Robert E; Oza, Bharvi; Lai, Catherine; Rowe, Julie H; Gowhari, Michel; Hassan, Johara; Desimone, Joseph; Machado, Roberto F; Gladwin, Mark T; Little, Jane A; Gordeuk, Victor R